Pharma

Your Article Summary

See Latest Articles

Cytokinetics Announces Advancement of CK-2017357 in Phase I Clinical Trials
Cytokinetics, 11/10/09

Cytokinetics, Incorporated announced the initiation of a double–blind, randomized, placebo–controlled, multiple–dose Phase I clinical trial to investigate the pharmacokinetic profile of CK–2017357. Cytokinetics also announced that the company has initiated the second part, or “Part B”, of a previously initiated first–time–in–humans, Phase I clinical trial of CK–2017357 in healthy male volunteers.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimers disease: a post hoc analysis
Current Medical Research and Opinion, 11/25/09

Pandemic 2009 Influenza Update: Pandemrix data in children and adolescents from 3 to 17 years of age
GlaxoSmithKline, 11/24/09

 See all of Drug Trials